Beyond the Hype: Psychedelics and the Future of Psychiatric Practice

Psychedelic therapies are generating significant attention as potential treatments for psychiatric conditions, but what does the evidence actually show? This session examines the emerging science surrounding psilocybin, MDMA, and other psychedelic therapies, including potential applications in depression, PTSD, and substance use disorders. Faculty will explore current evidence, safety and patient selection, therapeutic support, and the evolving regulatory landscape. Participants will leave better prepared to separate evidence from hype, respond to patient questions, and understand how these emerging therapies may shape the future of psychiatric practice.